The Big Ten Cancer Research Consortium: teaming up to fight cancer

Author(s): Susan Goodin, Robert S DiPaola & Patrick J Loehrer

The Institute of Medicine report in 2010 highlighted the need for changes in the framework for clinical cancer research in USA. The newly formed Big Ten Cancer Research Consortium was developed with attention to the challenges of clinical trial development, with special focus on collaborative science, the approval process and efficiencies in development and completion of clinical trials. The consortium provides for the development of team research with established leaders from academic institutions with an additional emphasis on mentoring junior investigators within and across institutions.